New research published in Neurology Open Access finds that maintaining normal blood pressure, avoiding type 2 diabetes, and not smoking between ages 45-68 is associated with nearly 13 more years of dementia-free life after age 55 compared to those with all three risk factors.
A new study demonstrates that a blood test measuring p-tau217 levels can identify healthy older adults at high risk of developing Alzheimer's symptoms within five to 10 years, potentially enabling early intervention as prevention trials advance.
The World Health Organization has issued updated global guidelines on reducing cognitive decline and dementia risk, stating that up to 45% of dementia cases may be preventable or delayed by addressing modifiable risk factors throughout life.
International research led by RIKEN Center for Integrative Medical Sciences discovered new associations between pathogenic BRCA1 and BRCA2 gene variants and four additional cancer types beyond the previously known breast and ovarian cancers.
Research published in the Canadian Medical Association Journal found that survivors of cancer during their teen and young adult years face twice the risk of developing most types of subsequent cancers compared to the general population.
Researchers published findings that Merck's experimental HIV prevention pill could be produced for less than $5 per year, urging the company to urgently begin licensing generic production to improve global access.
New research shows that influenza vaccination significantly reduces the risk of heart attack and stroke even among people who contract the flu after vaccination, demonstrating cardiovascular benefits beyond infection prevention.
Doctors Without Borders publicly criticized Gilead Sciences as 'unconscionable' after the company refused to provide even a limited supply of its HIV prevention drug lenacapavir following months of negotiations.
